Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage

Journal: Science

Published: 2020-08-21

DOI: 10.1126/science.aax0701

Affiliations: 57

Authors: 52

Go to article
Institutions Share
Institute Gustave-Roussy (IGR), France 0.12
Quebec Heart and Lung Institute (IUCPQ), UL, Canada 0.07
Tumour Immunology and Anti-Cancer Immunotherapy Unit, France 0.07
Department of Physics of Complex Systems, ELTE, Hungary 0.04
Laboratory of Biology and Genetics of Bacterial Cell Wall, France 0.04
Institut Hospitalo-Universitaire en Maladies Infectieuses de Marseille (IHU Méditerranée Infection), France 0.03
Microbes Evolution Phylogeny and Infections (MEPHI), France 0.03
LabEx Immuno Graft Oncology (IGO), France 0.03
IRCCS Regina Elena National Cancer Institute (IRE), Italy 0.03
IRCCS Department of Research, Advanced Diagnostics and Technological Innovation, Italy 0.03
Department of Microbiology, Pasteur Institute, France 0.03
Center for Research in Cancerology and Immunology Nantes-Angers (CRCINA), France 0.03
Cordelier Research Center (CRC), France 0.03
Bacterial Regulatory RNAs and Medicine (BRM), France 0.03
Computational Health Informatics Program (CHIP), BCH, United States of America (USA) 0.02
Integrative Tumor Immunology and Genetic Oncology, France 0.02
Department of Agricultural Sciences, UNINA, Italy 0.02
Équipe de Oncologie Médicale, CGFL, France 0.02
Centre de Recherche en Cancérologie de Toulouse (CRCT), France 0.02
Institut Universitaire du Cancer de Toulouse-Oncopole (IUCT-Oncopole), France 0.02
Centre for Integrative Biology (CIBIO), UNITN, Italy 0.02
Department of Medical Oncology, IGR, France 0.02
Predictive Biomarkers and Novel Therapeutic Strategies in Oncology, France 0.02
Sorbonne University, France 0.01
University of Paris, France 0.01
Immunologie-Immunopathologie-Immunothérapeutique (I3), France 0.01
National Institute for Health and Medical Research (INSERM), France 0.01
Clinical Investigation Center in Biotherapies and Immunology (CIC-BTi), DHU : I2B, France 0.01
University of Paris-Saclay, France 0.01
Cell Biology Platform, IGR, France 0.01
Metabolomics Platform, IGR, France 0.01
Saint Antoine Research Center (CRSA), France 0.01
Hospital of the University of Montreal (CHUM), Canada 0.01
Princess Maxima Centre for Pediatric Oncology (PMC), Netherlands 0.01
INCa-ICGC Breast Cancer Consortium, France 0.01
UNICANCER Group, France 0.01
Department of Tumor Biology and Pathology, CGFL, France 0.01
Suzhou Institute of Systems Medicine (ISM), CAMS & PUMC, China 0.01
Centre Georges-François Leclerc (CGFL), France 0.01
GIMI Genomic and Immunotherapy Medical Institute, France 0.01
Université Bourgogne Franche-Comté (UBFC), France 0.01
Department of Medicine, Surgery and Health Sciences, UNITS, Italy 0.01
Rennes University Hospital (CHU Rennes), France 0.01
Centre National de Référence (CNR) de la Résistance aux Antibiotiques, France 0.01
MTA-SE-NAP, Hungary 0
Danish Cancer Society Research Center (DCRC), Denmark 0
Harvard Medical School (HMS), United States of America (USA) 0
University Institute of Oncology of Asturias - Cajastur Social Programme (IUOPA), UniOvi, Spain 0
Departamento de Bioquímica y Biología Molecular (BBM), UniOvi, Spain 0
Department of Molecular Biology, UMU, Sweden 0
Laboratory for Molecular Infection Medicine Sweden (MIMS), UMU, Sweden 0
Georges Pompidou European Hospital (HEGP), France 0
Karolinska University Hospital, Sweden 0
University Institute of France (IUF), France 0

Return